786652-63-9 Usage
Uses
Used in Pharmaceutical Industry:
(3-Bromo-2-fluoro-phenyl)-acetic acid is used as a building block for the synthesis of various pharmaceutical compounds due to its unique halogenated aromatic structure. Its presence in these compounds can potentially enhance their biological activities and therapeutic effects.
Used in Drug Development:
(3-Bromo-2-fluoro-phenyl)-acetic acid serves as a starting material for the development of new drug candidates. Its unique structural features allow for the exploration of its potential as a precursor in the creation of novel therapeutic agents with improved efficacy and selectivity.
Used in Chemical Biology Research:
(3-Bromo-2-fluoro-phenyl)-acetic acid is utilized in chemical biology research to study its interactions with biological systems. Its halogenated structure makes it an interesting subject for investigating its potential roles in modulating biological processes and its applications in the discovery of new bioactive molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 786652-63-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,8,6,6,5 and 2 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 786652-63:
(8*7)+(7*8)+(6*6)+(5*6)+(4*5)+(3*2)+(2*6)+(1*3)=219
219 % 10 = 9
So 786652-63-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H6BrFO2/c9-6-3-1-2-5(8(6)10)4-7(11)12/h1-3H,4H2,(H,11,12)
786652-63-9Relevant academic research and scientific papers
SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE
-
Page/Page column 836; 837; 838, (2016/04/10)
Compounds having a structure of Formula (IX) or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b, Q1----Q2, R6, R7, A, B, W, x, and y are as defined herein and are provided. Pharmaceutical compositions comprising such compounds and methods for treating various HAT-related conditions or diseases, including cancer, by administration of such compounds are also provided.
HYDROXAMIC ACIDS USEFUL IN THE TREATMENT OF HYPER-PROLIFERATIVE DISORDERS
-
Page 306-307, (2010/02/09)
This invention relates to a compound of Formula (I) and its use in treating hyper-proliferative disorders.
